Literature DB >> 18296551

Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease.

G Karas1, J Sluimer, R Goekoop, W van der Flier, S A R B Rombouts, H Vrenken, P Scheltens, N Fox, F Barkhof.   

Abstract

BACKGROUND AND
PURPOSE: Mild cognitive impairment (MCI) is considered by many to be a prodromal phase of Alzheimer disease (AD). We used voxel-based morphometry (VBM) to find out whether structural differences on MR imaging could offer insight into the development of clinical AD in patients with amnestic MCI at 3-year follow-up.
MATERIALS AND METHODS: Twenty-four amnestic patients with MCI were included. After 3 years, 46% had progressed to AD (n = 11; age, 72.7 +/- 4.8 years; women/men, 8/3). For 13 patients (age, 72.4 +/- 8.6 years; women/men, 10/3), the diagnosis remained MCI. Baseline MR imaging at 1.5T included a coronal heavily T1-weighted 3D gradient-echo sequence. Localized gray matter differences were assessed with VBM.
RESULTS: The converters had less gray matter volume in medial (including the hippocampus) and lateral temporal lobe, parietal lobe, and lateral temporal lobe structures. After correction for age, sex, total gray matter volume, and neuropsychological evaluation, left-sided atrophy remained statistically significant. Specifically, converters had more left parietal atrophy (angular gyrus and inferior parietal lobule) and left lateral temporal lobe atrophy (superior and middle temporal gyrus) than stable patients with MCI.
CONCLUSION: By studying 2 MCI populations, converters versus nonconverters, we found atrophy beyond the medial temporal lobe to be characteristic of patients with MCI who will progress to dementia. Atrophy of structures such as the left lateral temporal lobe and left parietal cortex may independently predict conversion.

Entities:  

Mesh:

Year:  2008        PMID: 18296551      PMCID: PMC8128586          DOI: 10.3174/ajnr.A0949

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  36 in total

Review 1.  Voxel-based morphometry--the methods.

Authors:  J Ashburner; K J Friston
Journal:  Neuroimage       Date:  2000-06       Impact factor: 6.556

2.  "Voxel-based morphometry" should not be used with imperfectly registered images.

Authors:  F L Bookstein
Journal:  Neuroimage       Date:  2001-12       Impact factor: 6.556

3.  A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry.

Authors:  G B Karas; E J Burton; S A R B Rombouts; R A van Schijndel; J T O'Brien; P h Scheltens; I G McKeith; D Williams; C Ballard; F Barkhof
Journal:  Neuroimage       Date:  2003-04       Impact factor: 6.556

4.  Differential cortical atrophy in subgroups of mild cognitive impairment.

Authors:  Sandra Bell-McGinty; Oscar L Lopez; Carolyn Cidis Meltzer; Joelle M Scanlon; Ellen M Whyte; Steven T Dekosky; James T Becker
Journal:  Arch Neurol       Date:  2005-09

5.  Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI.

Authors:  C R Jack; M M Shiung; S D Weigand; P C O'Brien; J L Gunter; B F Boeve; D S Knopman; G E Smith; R J Ivnik; E G Tangalos; R C Petersen
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

6.  Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type.

Authors:  J C Morris
Journal:  Int Psychogeriatr       Date:  1997       Impact factor: 3.878

7.  MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD.

Authors:  Leyla deToledo-Morrell; T R Stoub; M Bulgakova; R S Wilson; D A Bennett; S Leurgans; J Wuu; D A Turner
Journal:  Neurobiol Aging       Date:  2004-10       Impact factor: 4.673

8.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

9.  Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.

Authors:  Alexander Drzezga; Nicola Lautenschlager; Hartwig Siebner; Matthias Riemenschneider; Frode Willoch; Satoshi Minoshima; Markus Schwaiger; Alexander Kurz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-23       Impact factor: 9.236

10.  Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.

Authors:  P Scheltens; D Leys; F Barkhof; D Huglo; H C Weinstein; P Vermersch; M Kuiper; M Steinling; E C Wolters; J Valk
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

View more
  67 in total

1.  Magnetic resonance imaging volume of the angular gyri predicts financial skill deficits in people with amnestic mild cognitive impairment.

Authors:  H Randall Griffith; Christopher C Stewart; Luke E Stoeckel; Ozioma C Okonkwo; Jan A den Hollander; Roy C Martin; Katherine Belue; Jacquelynn N Copeland; Lindy E Harrell; John C Brockington; David G Clark; Daniel C Marson
Journal:  J Am Geriatr Soc       Date:  2010-01-26       Impact factor: 5.562

2.  Exploring high-order functional interactions via structurally-weighted LASSO models.

Authors:  Dajiang Zhu; Xiang Li; Xi Jiang; Hanbo Chen; Dinggang Shen; Tianming Liu
Journal:  Inf Process Med Imaging       Date:  2013

3.  Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.

Authors:  Jonathan H Morra; Zhuowen Tu; Liana G Apostolova; Amity E Green; Christina Avedissian; Sarah K Madsen; Neelroop Parikshak; Arthur W Toga; Clifford R Jack; Norbert Schuff; Michael W Weiner; Paul M Thompson
Journal:  Neuroimage       Date:  2008-11-08       Impact factor: 6.556

4.  Regularized Modal Regression with Applications in Cognitive Impairment Prediction.

Authors:  Xiaoqian Wang; Hong Chen; Weidong Cai; Dinggang Shen; Heng Huang
Journal:  Adv Neural Inf Process Syst       Date:  2017-12

5.  Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease.

Authors:  Steven G Potkin; Guia Guffanti; Anita Lakatos; Jessica A Turner; Frithjof Kruggel; James H Fallon; Andrew J Saykin; Alessandro Orro; Sara Lupoli; Erika Salvi; Michael Weiner; Fabio Macciardi
Journal:  PLoS One       Date:  2009-08-07       Impact factor: 3.240

Review 6.  The clinical use of structural MRI in Alzheimer disease.

Authors:  Giovanni B Frisoni; Nick C Fox; Clifford R Jack; Philip Scheltens; Paul M Thompson
Journal:  Nat Rev Neurol       Date:  2010-02       Impact factor: 42.937

7.  [Mild cognitive impairment: diagnostic value of different MR techniques].

Authors:  T Hauser; P A Thomann; B Stieltjes; M Essig
Journal:  Radiologe       Date:  2011-04       Impact factor: 0.635

8.  Evidence for functional specialization of hippocampal subfields detected by MR subfield volumetry on high resolution images at 4 T.

Authors:  S G Mueller; L L Chao; B Berman; M W Weiner
Journal:  Neuroimage       Date:  2011-03-16       Impact factor: 6.556

Review 9.  Structural neuroimaging in the detection and prognosis of pre-clinical and early AD.

Authors:  Christine Fennema-Notestine; Linda K McEvoy; Donald J Hagler; Mark W Jacobson; Anders M Dale
Journal:  Behav Neurol       Date:  2009       Impact factor: 3.342

10.  Accelerating regional atrophy rates in the progression from normal aging to Alzheimer's disease.

Authors:  Jasper D Sluimer; Wiesje M van der Flier; Giorgos B Karas; Ronald van Schijndel; Josephine Barnes; Richard G Boyes; Keith S Cover; Sílvia D Olabarriaga; Nick C Fox; Philip Scheltens; Hugo Vrenken; Frederik Barkhof
Journal:  Eur Radiol       Date:  2009-07-18       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.